Book Excerpt from The Serengeti Rules

In the introduction to the book, author Sean B. Carroll draws the parallels between ecological and physiological maladies.

Written bySean B. Carroll
| 5 min read

Register for free to listen to this article
Listen with Speechify
0:00
5:00
Share

PRINCETON UNIVERSITY PRESS, FEBRUARY 2016Human life has changed immensely over the millennia, but never so much or so quickly as in the last century. For almost the entire 200,000-year existence of our species, Homo sapiens, biology controlled us. We gathered fruits, nuts, and plants, hunted and fished for the animals that were available, and like the wildebeest or zebra, we moved on when resources ran low. Even after the advent of farming and civilization, and the development of cities, we were still very vulnerable to the whims of the weather, and to famine and epidemics.

But in just the last hundred years or so, we have turned the tables and taken control of biology. Scourges such as smallpox, a virus that killed as many as 300 million people in the first part of the 20th century (far more than in all wars combined) was not merely tamed, it was eradicated from the planet. Tuberculosis, caused by a bacterium that infected 70-90% of all urban residents in the 19th century and killed perhaps one in seven Americans, has nearly vanished from the developed world. More than two dozen other vaccines now prevent diseases that once infected, crippled, or killed millions, including polio, measles, and pertussis. Deadly diseases that did not exist in the nineteenth century, such as HIV/AIDS, have been stopped ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies